cbdMD (YCBD) Return on Capital Employed Growth (3y) (2020 - 2026)
cbdMD (YCBD) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 4,484.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,484.00 |
| Dec 31, 2025 | 14,641.00 |
| Sep 30, 2025 | 14,813.00 |
| Jun 30, 2025 | 7,514.00 |
| Mar 31, 2025 | -4,433.00 |
| Dec 31, 2024 | -8,261.00 |
| Sep 30, 2024 | -7,492.00 |
| Jun 30, 2024 | -27,196.00 |
| Mar 31, 2024 | -23,907.00 |
| Dec 31, 2023 | -18,971.00 |
| Sep 30, 2023 | -9,593.00 |
| Jun 30, 2023 | -5,991.00 |
| Mar 31, 2023 | -15,530.00 |
| Dec 31, 2022 | -15,340.00 |
| Sep 30, 2022 | -16,344.00 |
| Jun 30, 2022 | -8,847.00 |
| Mar 31, 2022 | -4,293.00 |
| Dec 31, 2021 | -3,787.00 |
| Sep 30, 2021 | -515.00 |
| Jun 30, 2021 | -1,988.00 |